Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours

Bunganič, Bohuš; Laclav, Martin; Dvořáková, Tereza; Bradáč, Ondřej; Traboulsi, Eva; Suchánek, Štěpán; Frič, P; Zavoral, Miroslav

doi:10.1080/00365521.2018.1524023

Cited by 21 publications

(16 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…83.1%) and accuracy (84.1% vs . 78.6%) than conventional EUS [ 13 ]. The results of a meta‐analysis also showed excellent pooled estimates of sensitivity and specificity of CEH EUS for pancreatic cancer diagnosis, at 93% (95% CI = 0.91–0.95) and 80% (95% CI = 0.75–0.85) respectively [ 56 ].…”

Section: Types Of Examinationmentioning

confidence: 99%

“…Over the last few years, EUS‐FNA has been considered the most advanced and accurate diagnostic technique in patients with suspected pancreatic cancer. Among those with pancreatic lesions detected by CT, the sensitivity, specificity, and accuracy of EUS‐FNA were 87.6%, 91.2%, and 88.8%, respectively [ 13 ]. A prospective single‐center study from South China reported that EUS‐FNA had a sensitivity, specificity, and accuracy of 77.8%, 100%, and 84% for pancreatic cancer diagnosis [ 59 ].…”

Section: Types Of Examinationmentioning

confidence: 99%

“…Additionally, magnetic resonance imaging/cholangiopancreatography (MRI/MRCP), EUS, EUS‐guided fine‐needle aspiration (EUS‐FNA), and endoscopic retrograde cholangiopancreatography (ERCP) also play important roles in diagnosing pancreatic cancer. Many technological innovations of imaging or endoscopy are being applied to improve the diagnostic accuracy of pancreatic tumors [ 11 , 12 , 13 ]. Serological tests are also important auxiliary diagnostic methods for pancreatic cancer.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

Yang

Wang

et al. 2021

Cancer Communications

160

View full text Add to dashboard Cite

Pancreatic cancer is a highly malignant digestive system tumor with a poor prognosis. Most pancreatic cancer patients are diagnosed at an advanced stage or even metastasis due to its highly aggressive characteristics and lack of typical early symptoms. Thus, an early diagnosis of pancreatic cancer is crucial for improving its prognosis. Currently, screening is often applied in high-risk individuals to achieve the early diagnosis of pancreatic cancer. Fully understanding the risk factors of pancreatic cancer and pathogenesis could help us identify the high-risk population and achieve early diagnosis and timely treatment of pancreatic cancer. Notably, accumulating studies have been undertaken to improve the detection rate of different imaging methods and the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) which is the golden standard for pancreatic cancer diagnosis. In addition, there are currently

show abstract

Section: Types Of Examinationmentioning

confidence: 99%

Section: Types Of Examinationmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

Yang

Wang

et al. 2021

Cancer Communications

160

View full text Add to dashboard Cite

show abstract

“…In this study, CH-EUS and EUS-FNA had high accuracy, with sensitivity of 95% and 96%, of 95% and 93% (p < 0.05). Bunganič et al reported that the IOR of pancreatic adenocarcinoma diagnosis by EUS and CH-EUS was moderate (K = 0.45 and 0.60, respectively) [38]. The sensitivity and specificity of EUS and CH-EUS for pancreatic adenocarcinoma diagnosis were, respectively, 83.1% and 62.5% and 94.5% and 61.7%.…”

Section: Solid Pancreatic Lesionmentioning

confidence: 99%

Interobserver Reliability of Endoscopic Ultrasonography: Literature Review

et al. 2020

View full text Add to dashboard Cite

Endoscopic ultrasonography (EUS) has been applied to the diagnosis of various digestive disorders. Although it has been widely accepted and its diagnostic value is high, the dependence of EUS diagnosis on image interpretation done by the endosonographer has persisted as an important difficulty. Consequently, high interobserver reliability (IOR) in EUS diagnosis is important to demonstrate the reliability of EUS diagnosis. We reviewed the literature on the IOR of EUS diagnosis for various diseases such as chronic pancreatitis, pancreatic solid/cystic mass, lymphadenopathy, and gastrointestinal and subepithelial lesions. The IOR of EUS diagnosis differs depending on the disease; moreover, EUS findings with high IOR and those with IOR that was not necessarily high were used as diagnostic criteria. Therefore, to further increase the value of EUS diagnosis, EUS diagnostic criteria with high diagnostic characteristics based on EUS findings with high IOR must be established.

show abstract

“…3,4 TH-EUS decreases tissue artifact like shadowing. 4 Recent studies show that CH-EUS depicts the hypoenhancement of pancreatic carcinomas with high sensitivity and specificity, [2][3][4][5][6][7][8][9][10][11][12][13][14][15] although there are no standard diagnostic criteria because the definition of pancreatic carcinoma on CH-EUS differs among the previous reports. The evaluation of TH-EUS and CH-EUS findings may be influenced by the subjective impression of individual endosonographers, and the reproducibility of these methods is unknown.…”

Section: Introductionmentioning

confidence: 99%

Tissue harmonic versus contrast‐enhanced harmonic endoscopic ultrasonography for the diagnosis of pancreatic tumors: Prospective multicenter study

Omoto

Kitano

Fukasawa

et al. 2021

Digestive Endoscopy

View full text Add to dashboard Cite

Objectives: This prospective multicenter study aimed to assess and compare the accuracy of tissue harmonic endoscopic ultrasonography (TH-EUS) and contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) for differentiating pancreatic carcinoma from other pancreatic tumors. Methods:Consecutive patients with solid pancreatic tumors were prospectively enrolled between August 2013 and December 2014. To assess the accuracy of TH-EUS and CH-EUS, we compared four parameters of TH-EUS (fuzzy edge, irregular periphery, hypoechogenicity, and heterogeneous internal echogenicity) and four parameters of CH-EUS (hypoenhancement and heterogeneous enhancement in the early and late phases, respectively) to investigate which parameter of each method was most suitable to diagnose pancreatic carcinomas. Interobserver agreement and the diagnostic ability of pancreatic carcinoma using TH-EUS and CH-EUS were assessed and compared.Results: A total of 204 patients were enrolled. For the diagnosis of pancreatic carcinoma, interobserver agreement by experts and nonexperts was 0.33-0.50 and 0.35-0.50 for TH-EUS, respectively, and 0.72-0.74 and 0.20-0.54 for CH-EUS, respectively. Irregular periphery was the most accurate diagnostic parameter among TH-EUS findings for differentiating pancreatic carcinomas, with sensitivity, specificity, and accuracy of 95.0%, 42.9%, and 78.9%, respectively. Late phase hypoenhancement was the most accurate diagnostic parameter among CH-EUS findings for differentiating pancreatic carcinomas, with sensitivity, specificity, and accuracy of 90.8%, 74.6%, and 85.8%, respectively. The accuracy of CH-EUS (late phase hypoenhancement) for diagnosis of pancreatic carcinoma was significantly higher than that of TH-EUS (irregular periphery) (p < 0.001). Conclusion:In comparison with TH-EUS, CH-EUS increased the diagnostic ability and reproducibility for the diagnosis of pancreatic carcinoma. UMIN (000011124).

show abstract

Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours

Cited by 21 publications

References 22 publications

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

Interobserver Reliability of Endoscopic Ultrasonography: Literature Review

Tissue harmonic versus contrast‐enhanced harmonic endoscopic ultrasonography for the diagnosis of pancreatic tumors: Prospective multicenter study

Contact Info

Product

Resources

About